Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials
In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland
Recision, 1981 Budget Threats Hangover NCI
Frelick Heads ACCC, Kerman Names President-Elect
CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients
Skipper To Receive Bristol-Myers Award
Pathology Review Confirms Reserpine As Carcinogen
Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer - Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science
- The defining question of the next decade is not how many drug candidates can be generated, but who decides which ones move forward, and why
Drug development must convene a forum for candid, cross-sector discussion
